Inflammation Reduction: Explore the peptides potential anti-inflammatory effects, beneficial for studying chronic conditions and injury recovery
Throughout, he underscores the importance of aligning sexual health with overall healthspan and lifespan
Animal Toxicology Studies Animal toxicology studies tested doses from 0.0027 mg/lb to 9.1 mg/lb via intraperitoneal, intramuscular, intravenous, and oral routes for up to 6 weeks, finding: No acute toxic or lethal dose No gross or histologic toxicity in major organs No hepatotoxicity or nephrotoxicity Negative Ames test (no mutagenicity) Negative chromosomal aberration tests (no genotoxicity) No teratogenicity in rat pregnancy studies No local injection site irritation The LD1 (minimum lethal dose) could not be achieved despite aggressive testing
mechanism remains an active area of study
Infection signs, worsening injuries, or unusual neurologic symptoms need symptom-based review
Conditions That Respond to Anti-Inflammatory Peptide Therapy Peptide therapy for inflammation shows promise across a diverse range of conditions